Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19581537

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2009 Aug 10
First author
Poplin E

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2009 Dec 1;27(34):5859
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null

Authors and identifiers

  1. name
    Poplin E
    type
    Author
  2. name
    Feng Y
    type
    Author
  3. name
    Berlin J
    type
    Author
  4. name
    Rothenberg ML
    type
    Author
  5. name
    Hochster H
    type
    Author
  6. name
    Mitchell E
    type
    Author
  7. name
    Alberts S
    type
    Author
  8. name
    O'Dwyer P
    type
    Author
  9. name
    Haller D
    type
    Author
  10. name
    Catalano P
    type
    Author
  11. name
    Cella D
    type
    Author
  12. name
    Benson AB 3rd
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Poplin E
    type
    Author
  2. name
    Feng Y
    type
    Author
  3. name
    Berlin J
    type
    Author
  4. name
    Rothenberg ML
    type
    Author
  5. name
    Hochster H
    type
    Author
  6. name
    Mitchell E
    type
    Author
  7. name
    Alberts S
    type
    Author
  8. name
    O'Dwyer P
    type
    Author
  9. name
    Haller D
    type
    Author
  10. name
    Catalano P
    type
    Author
  11. name
    Cella D
    type
    Author
  12. name
    Benson AB 3rd
    type
    Author
bibliography ids
  1. nci-bib-328dd90ab77ddecc0ffd325e
book metadata
content sha256
a98ca2166708991883e9bc41e9dc474af270bce70ead335252d3d3e6ac874029
document type
citation
dois
  1. 10.1200/JCO.2008.20.9007
electronic publication date
display
2009 Jul 6
precision
day
year
2009
evidence scope
bibliographic_metadata_only
id
pubmed:19581537
immutable id
pubmed:19581537@a98ca2166708991883e9bc41e9dc474af270bce70ead335252d3d3e6ac874029
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
23
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3778-85
volume
27
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2009 Dec 1;27(34):5859
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
outcomes validated
false
pmid
19581537
provenance
batch id
4f803f1a8e7b4f56d2f1
provider
NCBI PubMed ESummary
record sha256
19b439a0990956dc3ff8cc316aec334fcdcd49c20464b42e4f91c2a67d94a6b9
response sha256
fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
retrieved at
2026-09-09T23:46:26.391289+00:00
publication date
display
2009 Aug 10
precision
day
year
2009
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/19581537/
title
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

Preserved source evidence · Not medical advice